Mohamadian M, Fallah H, Ghofrani-Jahromi Z, Rahimi-Danesh M, Shokouhi Qare Saadlou M, Vaseghi S
Naunyn Schmiedebergs Arch Pharmacol. 2023; 396(7):1339-1359.
PMID: 36843130
DOI: 10.1007/s00210-023-02437-1.
Ananth M, Bartlett E, DeLorenzo C, Lin X, Kunkel L, Vadhan N
Eur J Nucl Med Mol Imaging. 2020; 47(10):2417-2428.
PMID: 32055965
PMC: 8789023.
DOI: 10.1007/s00259-020-04681-6.
Dziedzicka-Wasylewska M, Mackowiak M, Fijat K, Wedzony K
J Neural Transm (Vienna). 1996; 103(7):765-76.
PMID: 8872863
DOI: 10.1007/BF01273357.
Baptista T, Teneud L, Contreras Q, Burguera J, Burguera M, Hernandez L
J Neural Transm Gen Sect. 1993; 94(2):75-89.
PMID: 7509157
DOI: 10.1007/BF01245002.
Banay-Schwartz M, Wajda I, Manigault I, Deguzman T, Lajtha A
Neurochem Res. 1982; 7(2):179-89.
PMID: 7121707
DOI: 10.1007/BF00965056.
Clinical and neuropathological aspects of long-term damage to the central nervous system after lithium medication.
PEIFFER J
Arch Psychiatr Nervenkr (1970). 1981; 231(1):41-60.
PMID: 6797383
DOI: 10.1007/BF00342829.
The effect of long-term concurrent administration of chlorpromazine and lithium on the striatal and frontal cortical dopamine metabolism in rats.
Eroglu L, Hizal A, KOYUNCUOGLU H
Psychopharmacology (Berl). 1981; 73(1):84-6.
PMID: 6785796
DOI: 10.1007/BF00431108.
Comparison of acute and chronic lithium treatment on 3H-norepinephrine uptake by rat brain slices.
Cameron O, Smith C
Psychopharmacology (Berl). 1980; 67(1):81-5.
PMID: 6768082
DOI: 10.1007/BF00427599.
Lithium does not interact with haloperidol in the dopaminergic pathways of the rat brain.
Reches A, Jackson-Lewis V, Fahn S
Psychopharmacology (Berl). 1984; 82(4):330-4.
PMID: 6427824
DOI: 10.1007/BF00427680.
Dopamine and mania: behavioral and biochemical effects of the dopamine receptor blocker pimozide.
Post R, Jimerson D, Bunney Jr W, Goodwin F
Psychopharmacology (Berl). 1980; 67(3):297-305.
PMID: 6155678
DOI: 10.1007/BF00431272.
Effect of lithium on central metabolism of 5-hydroxytryptamine.
Poitou P, Guerinot F, Bohuon C
Psychopharmacologia. 1974; 38(1):75-80.
PMID: 4851658
DOI: 10.1007/BF00421289.
Effect of chronic lithium treatment on monoamine metabolism in rat brain.
Schubert J
Psychopharmacologia. 1973; 32(3):301-11.
PMID: 4762238
DOI: 10.1007/BF00422153.
[Orientational study on the plasma tyrosine circadian rhythm in depressive syndromes of various etiology].
Klempel K
Arch Psychiatr Nervenkr (1970). 1972; 216(2):131-52.
PMID: 4640743
DOI: 10.1007/BF00346415.
Lithium and chlorpromazine: a controlled crossover study of hyperactive severely disturbed young children.
Campbell M, Fish B, Korein J, Shapiro T, Collins P, Koh C
J Autism Child Schizophr. 1972; 2(3):234-63.
PMID: 4567547
DOI: 10.1007/BF01537617.
Biochemical evidence of adrenergic interaction with cholinergic function in the central nervous system of the rat. 1. Effect of norepinephrine.
Ho A, Singer G, Gershon S
Psychopharmacologia. 1971; 21(3):238-46.
PMID: 4328762
DOI: 10.1007/BF00403862.
Further evidence for the heterogeneous storage of noradrenaline in central noradrenergic terminals.
Thierry A, Blanc G, Glowinski J
Naunyn Schmiedebergs Arch Pharmacol. 1973; 279(3):255-66.
PMID: 4147967
DOI: 10.1007/BF00500605.
Activity of tuberoinfundibular dopaminergic neurons and concentrations of serum prolactin in the rat following lithium administration.
Gudelsky G, Koenig J, Koyama T, Meltzer H
Psychopharmacology (Berl). 1988; 94(1):92-6.
PMID: 3126532
DOI: 10.1007/BF00735887.
The effect of short-term lithium administration on noradrenaline metabolism in the limbic forebrain and hemispheres of rats.
Berggren U
J Neural Transm. 1988; 73(1):71-5.
PMID: 2841421
DOI: 10.1007/BF01244624.
Effect of chronic lithium administration on adrenoceptor binding and adrenoceptor regulation in rat cerebral cortex.
Gross G, Dodt C, Hanft G
Naunyn Schmiedebergs Arch Pharmacol. 1988; 337(3):267-72.
PMID: 2839778
DOI: 10.1007/BF00168837.
Long-term lithium treatment in rats attenuates m-chlorophenylpiperazine-induced decreases in food intake but not locomotor activity.
Aulakh C, Zohar J, Wozniak K, Hill J, Murphy D
Psychopharmacology (Berl). 1989; 98(4):448-52.
PMID: 2505284
DOI: 10.1007/BF00441940.
